共 50 条
Multiplex Reverse Transcription-Polymerase Chain Reaction as Diagnostic Molecular Screening of 4 Common Fusion Chimeric Genes in Taiwanese Children With Acute Lymphoblastic Leukemia
被引:8
|作者:
Yang, Yung-Li
[1
,2
,4
]
Lin, Shu-Rung
[6
]
Chen, Jiann-Shiuh
[7
]
Hsiao, Chih-Cheng
[8
]
Lin, Kai-Hsin
[2
]
Sheen, Jiunn-Ming
[8
]
Cheng, Chao-Neng
[7
]
Wu, Kang-Hsi
[9
]
Lin, Shu-Wha
[3
]
Yu, Sung-Liang
[3
]
Chen, Hsuan-Yu
[5
]
Lu, Meng-Yao
[2
]
Chang, Hsiu-Hao
[2
,3
]
Yen, Ching-Tzu
[3
]
Lin, Jing-Fang
[3
]
Su, Ying-Hui
[3
]
Li, Ya-Ping
Lin, Chien-Yu
[5
]
Jou, Shiann-Tarng
[2
]
Lin, Dong-Tsamn
[1
,2
]
机构:
[1] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan
[2] Natl Taiwan Univ Hosp, Dept Pediat, Taipei, Taiwan
[3] Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei 100, Taiwan
[4] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 100, Taiwan
[5] Acad Sinica, Inst Stat Sci, Taipei 11529, Taiwan
[6] Chung Yuan Christian Univ, Coll Sci, Dept Biosci Technol, Tao Yuan, Taiwan
[7] Natl Cheng Kung Univ Hosp, Dept Pediat, Tainan 70428, Taiwan
[8] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Kaohsiung Med Ctr,Dept Pediat, Kaohsiung, Taiwan
[9] China Med Univ Hosp, Dept Pediat, Taichung, Taiwan
关键词:
childhood acute lymphoblastic leukemia (ALL);
multiplex PCR;
ETV6-RUNX1;
RT-PCR ASSAY;
TEL/AML1;
FUSION;
PROGNOSTIC-SIGNIFICANCE;
TREATMENT RESPONSE;
ONCOLOGY GROUP;
TRIALS;
REARRANGEMENT;
PROTOCOL;
THERAPY;
GERMAN;
D O I:
10.1097/MPH.0b013e3181ed1655
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
Background: The classification of B-lineage acute lymphoblastic leukemia (ALL) by specific chromosomal translocations has prognostic implications for risk-directed therapy. Reverse transcription-polymerase chain reaction (RT-PCR) assay is a useful tool for detecting fusion transcripts from common chromosomal translocations of ALL cells. Methods: Multiplex RT-PCR and nested-PCR assays were used to detect ALL-type BCR-ABL1 transcripts of the t(9; 22), TCF-PBX1 transcripts of t(1; 19), the MLL-AF4 transcripts of t(4; 11), and 2 variants of ETV6-RUNX1 of the cryptic t(12; 21) in 148 leukemic samples upon diagnosis. The patients received risk-directed protocols of the Taiwan Pediatric Oncology Group-ALL-2002 that consisted of multiple chemotherapeutic agents of different intensities. Event-free survival (EFS) and overall survival (OS) rates were analyzed for genetic abnormalities detected by multiplex PCR and conventional cytogenetic analysis by the Kaplan-Meier method, and compared with the Mantel-Haenszel test. The Cox proportional hazards model was implemented to identify independent prognostic factors for EFS and OS. Results: In this cohort of Taiwanese children, the relative frequencies of the 4 translocations of B-lineage ALL were 8% with ALL-type t(9; 22)/BCR-ABL1, 4% with (1; 19)/TCF-PBX1, 2% with t(4; 11)/MLL-AF4, and 17.6% with t(12; 21)/ETV6-RUNX1. Patients with t(12; 21)/ETV6-RUNX1 fusion, hyperdiploidy, and t(1; 19)/TCF-PBX1 fusion had the most favorable outcomes, whereas those with the t(9; 22)/BCR-ABL1 fusion or t(4; 11) and other MLL gene rearrangement had poor prognosis (P<0.001 for EFS and OS). BCR-ABL1, MLL gene rearrangement, and very high-risk group were independent prognostic factors after Cox regression analysis. Conclusions: The biological factors of leukemia cells are associated with treatment outcomes in childhood ALL. Multiplex RT-PCR assay is an efficient and sensitive diagnostic tool that may improve the ability to accurately and rapidly risk-stratify children with ALL.
引用
收藏
页码:E323 / E330
页数:8
相关论文